April Meeting (Zoom) 04/13/2022

Smartphone, M.D: Smartphone and Spit Test for COVID and Flu

Our speaker will discuss a smartphone-based COVID and influenza diagnostic test that is among the most rapid, sensitive, affordable, and scalable tests known. It can be readily adapted for other pathogens with pandemic potential including novel COVID variants and influenza, and it provides a platform for inexpensive home-based testing. His lab has provided the app and technology on an open-source basis, which is freely available to all to help reduce the world’s inequities.

Dr. Michael Mahan, Professor at UCSB's Department of Molecular, Cellular, and Developmental Biology, received his Ph.D. in Genetics from the University of Utah. He was an NIH post-doctoral fellow at Harvard Medical School where he began his work on the molecular mechanisms underlying salmonella pathogenesis. Dr. Mahan joined the UCSB faculty in 1993 and was a co-founder and director of Remedyne Corporation, a biotech company in Santa Barbara.